| ACTU Past Earnings | ||||||||||||||||||||||||||||||
|
|
|
Actuate Therapeutics Past Earnings
ACTU Past Earnings
— Presenting past earnings and revenue for Actuate Therapeutics (ACTU) from Q2 2024 to Q2 2026, based on our latest update on 8/19/2026. The past earnings numbers are per-share values while the revenue is the grand total for the quarter. Studying these ACTU past earnings numbers both in chart format and in tables can help investors visualize any typical seasonality patterns, as well as determine whether the company has grown over time.| ACTU Past Revenue | ||||||||||||||||||||||||||||||
|
| ACTU Current Stock Quote |
Quotes delayed 20 minutes  Free ACTU Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| ACTU Stock Price Chart |
| Featured Articles |
| Past Earnings Peers |
| Actuate Therapeutics (ACTU) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:
ACXP Past Earnings ADGI Past Earnings ADIL Past Earnings ADMA Past Earnings ADMP Past Earnings ADMS Past Earnings ADPT Past Earnings ADTX Past Earnings ADUS Past Earnings ADVM Past Earnings |
ACTU Past Earnings Q&A
What was the best and worst ACTU past earnings results?
For Actuate Therapeutics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?
For Actuate Therapeutics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?
✔️Accepted answer:
The highest ACTU past earnings result in our data set was -0.180/share posted in Q4 2025, while the lowest was in Q2 2024 when ACTU posted -4.200/share.
Suggested answer:
The biggest top line earnings performance — aka revenue — quarter was in Q2 2026 when ACTU reported NA in revenue, while the quarter with the lowest revenue in our data set was Q2 2026 at NA of revenue.
Suggested answer:
There are 9 ACTU past earnings results in our data set.
On this page we presented the ACTU past earnings date information for Actuate Therapeutics. Reviewing that
ACTU Past Earnings for the company, we see that the highest past earnings result in our data set was in Q4 2025, when ACTU posted gaap of -0.180/share. Meanwhile the lowest ACTU past earnings result was in Q2 2024, when ACTU posted gaap of -4.200/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q2 2026 when ACTU reported NA in revenue, while the smallest revenue quarter was Q2 2026 when ACTU reported NA in revenue.
Any self directed investor doing their due diligence on ACTU or any other given stock can benefit from researching all of the Actuate Therapeutics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Actuate Therapeutics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for ACTU. Thanks for visiting, and the next time you need to research ACTU past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.
Also recommended: Top Ten Hedge Funds Holding IMUC, Institutional Holders of MKTY, FREE Options Chain.
ACTU Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2026, All Rights Reserved
Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.